Munich, Germany

Klaus Karg

This inventor holds 1 USPTO granted patent. Top assignee: Tvns Technologies Gmbh. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus Karg - Innovator in tVNS Treatment Technology

Introduction

Klaus Karg is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical technology, particularly in the area of transcutaneous vagus nerve stimulation (tVNS). His innovative approach has led to the development of a unique device that enhances treatment options for patients.

Latest Patents

Klaus Karg holds a patent for a "Device for performing a tVNS treatment." This invention features at least one electrode designed to generate a stimulation pulse. The device is equipped with detection means that can monitor one or more parameter values. Additionally, it includes a control or regulation unit that adjusts the stimulation pulse parameters based on the detected values. This advancement represents a significant step forward in non-invasive medical treatments.

Career Highlights

Klaus Karg has dedicated his career to advancing medical technology. His work at Tvns Technologies GmbH has positioned him as a leader in the development of innovative solutions for tVNS treatments. His commitment to improving patient care through technology is evident in his patent and ongoing research efforts.

Collaborations

Klaus collaborates with Armin Bolz, a fellow innovator in the field. Together, they work on enhancing the capabilities of tVNS technology and exploring new applications for their inventions.

Conclusion

Klaus Karg's contributions to the field of tVNS treatment technology highlight his role as a pioneering inventor. His patented device represents a significant advancement in medical technology, showcasing his dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…